Kennedy R. Lees
University of Glasgow
467 Papers
3.9K Citations
Kennedy R. Lees is an academic researcher from University of Glasgow. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 86, co-authored 455 publications. Previous affiliations of Kennedy R. Lees include Ludwig Maximilian University of Munich & Cedars-Sinai Medical Center.
Chat about Author
Papers
Perindopril. A review of its pharmacokinetics and clinical pharmacology.
TL;DR: Perindopril is an orally active, non-thiol angiotensin-converting enzyme (ACE) inhibitor, which in doses of 4 to 8mg is effective in the control of essential hypertension as discussed by the authors.
Pharmacokinetics of a glycine site antagonist (gavestinel) following multiple dosing in patients with acute stroke
J. Hoke,Alexander G. Dyker,R. Barnaby,Kennedy R. Lees +3 more
TL;DR: The pharmacokinetics of gavestinel following multiple doses in acute stroke patients showed that the pharmacokinetic are similar for increasing maintenance doses, and the high protein binding of gAVestinel was confirmed in acute Stroke patients.
METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research
Martin Dichgans,Joanna M. Wardlaw,Eric E. Smith,Vera Zietemann,Sudha Seshadri,Perminder S. Sachdev,Geert J. Biessels,Franz Fazekas,Oscar R. Benavente,Leonardo Pantoni,Frank-Erik de Leeuw,Bo Norrving,Paul M. Matthews,Christopher Chen,Vincent Mok,Marco Düring,William Whiteley,Kirsten Shuler,Alvaro Alonso,Sandra E. Black,Carol Brayne,Hugues Chabriat,Charlotte Cordonnier,Fergus N. Doubal,Emrah Düzel,Michael Ewers,Richard Frayne,Vladimir Hachinski,Mohammad Arfan Ikram,Frank Jessen,Eric Jouvent,Jennifer Linn,John T. O'Brien,Robert J. van Oostenbrugge,Rainer Malik,Bernard Mazoyer,Reinhold E. Schmidt,Luciano A. Sposato,Blossom C. M. Stephan,Richard H. Swartz,Meike W. Vernooij,Anand Viswanathan,David J. Werring,Koji Abe,Louise Allan,Francesco Arba,Hans-Christoph Diener,Stephen N. Davis,Graeme J. Hankey,Kennedy R. Lees,Bruce Ovbiagele,Christopher J. Weir,Hee-Joon Bae,Philip M.W. Bath,Régis Bordet,Monique M.B. Breteler,Seong Hye Choi,Ian J. Deary,Charles DeCarli,Klaus P. Ebmeier,Lei Feng,Steven M. Greenberg,Masafumi Ihara,Rajesh N. Kalaria,San Yun Kim,Jae-Sung Lim,Richard I. Lindley,Gillian Mead,Alison D. Murray,Terry J Quinn,Craig W. Ritchie,Ralph L. Sacco,Rustam Al-Shahi Salman,Nikola Sprigg,Cathie Sudlow,Alan J. Thomas,Martin P.J. van Boxtel,Jeroen van der Grond,Aad van der Lugt,Yuan-Han Yang +79 more
TL;DR: The enthusiastic response means that cohorts from North America, Australasia, and the Asia Pacific Region are included, creating a truly global, collaborative, data sharing platform, linked to major national dementia initiatives.
Reliability of the modified Rankin Scale
TL;DR: There remains uncertainty regarding modified Rankin Scale reliability, and interobserver studies closest in design to large-scale clinical trials demonstrate potentially significant in...
International survey of acute Stroke imaging used to make revascularization treatment decisions
Max Wintermark,Marie Luby,Marie Luby,Natan M. Bornstein,Andrew M. Demchuk,Jens Fiehler,Kohsuke Kudo,Kennedy R. Lees,David S Liebeskind,Patrik Michel,Raul G. Nogueira,Mark W Parsons,Makoto Sasaki,Joanna M. Wardlaw,Ona Wu,Weiwei Zhang,Guangming Zhu,Steven Warach +17 more
TL;DR: Clinical trials using advanced imaging as a selection tool for acute revascularization therapy should address the need for additional resources and technical support, and take into consideration the lack of routine use of such techniques in trial planning.